BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 25775548)

  • 1. Altered cofactor regulation with disease-associated p97/VCP mutations.
    Zhang X; Gui L; Zhang X; Bulfer SL; Sanghez V; Wong DE; Lee Y; Lehmann L; Lee JS; Shih PY; Lin HJ; Iacovino M; Weihl CC; Arkin MR; Wang Y; Chou TF
    Proc Natl Acad Sci U S A; 2015 Apr; 112(14):E1705-14. PubMed ID: 25775548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific inhibition of p97/VCP ATPase and kinetic analysis demonstrate interaction between D1 and D2 ATPase domains.
    Chou TF; Bulfer SL; Weihl CC; Li K; Lis LG; Walters MA; Schoenen FJ; Lin HJ; Deshaies RJ; Arkin MR
    J Mol Biol; 2014 Jul; 426(15):2886-99. PubMed ID: 24878061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In silico prediction, characterization, docking studies and molecular dynamics simulation of human p97 in complex with p37 cofactor.
    Mirzadeh A; Kobakhidze G; Vuillemot R; Jonic S; Rouiller I
    BMC Mol Cell Biol; 2022 Sep; 23(1):39. PubMed ID: 36088301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The N-terminal Region of the Ubiquitin Regulatory X (UBX) Domain-containing Protein 1 (UBXD1) Modulates Interdomain Communication within the Valosin-containing Protein p97.
    Trusch F; Matena A; Vuk M; Koerver L; Knævelsrud H; Freemont PS; Meyer H; Bayer P
    J Biol Chem; 2015 Dec; 290(49):29414-27. PubMed ID: 26475856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conserved L464 in p97 D1-D2 linker is critical for p97 cofactor regulated ATPase activity.
    Zhang X; Gui L; Li S; Nandi P; Columbres RC; Wong DE; Moen DR; Lin HJ; Chiu PL; Chou TF
    Biochem J; 2021 Sep; 478(17):3185-3204. PubMed ID: 34405853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of the N-domain in the ATPase activity of the mammalian AAA ATPase p97/VCP.
    Niwa H; Ewens CA; Tsang C; Yeung HO; Zhang X; Freemont PS
    J Biol Chem; 2012 Mar; 287(11):8561-70. PubMed ID: 22270372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating p97 Inhibitor Analogues for Potency against p97-p37 and p97-Npl4-Ufd1 Complexes.
    Gui L; Zhang X; Li K; Frankowski KJ; Li S; Wong DE; Moen DR; Porubsky PR; Lin HJ; Schoenen FJ; Chou TF
    ChemMedChem; 2016 May; 11(9):953-7. PubMed ID: 27043824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p97 Disease Mutations Modulate Nucleotide-Induced Conformation to Alter Protein-Protein Interactions.
    Bulfer SL; Chou TF; Arkin MR
    ACS Chem Biol; 2016 Aug; 11(8):2112-6. PubMed ID: 27267671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ATP binding to p97/VCP D1 domain regulates selective recruitment of adaptors to its proximal N-domain.
    Chia WS; Chia DX; Rao F; Bar Nun S; Geifman Shochat S
    PLoS One; 2012; 7(12):e50490. PubMed ID: 23226521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hereditary inclusion body myopathy-linked p97/VCP mutations in the NH2 domain and the D1 ring modulate p97/VCP ATPase activity and D2 ring conformation.
    Halawani D; LeBlanc AC; Rouiller I; Michnick SW; Servant MJ; Latterich M
    Mol Cell Biol; 2009 Aug; 29(16):4484-94. PubMed ID: 19506019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction between the AAA
    Rao MV; Williams DR; Cocklin S; Loll PJ
    J Biol Chem; 2017 Nov; 292(45):18392-18407. PubMed ID: 28939772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A unique IBMPFD-related P97/VCP mutation with differential binding pattern and subcellular localization.
    Erzurumlu Y; Kose FA; Gozen O; Gozuacik D; Toth EA; Ballar P
    Int J Biochem Cell Biol; 2013 Apr; 45(4):773-82. PubMed ID: 23333620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered intersubunit communication is the molecular basis for functional defects of pathogenic p97 mutants.
    Tang WK; Xia D
    J Biol Chem; 2013 Dec; 288(51):36624-35. PubMed ID: 24196964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different dynamic movements of wild-type and pathogenic VCPs and their cofactors to damaged mitochondria in a Parkin-mediated mitochondrial quality control system.
    Kimura Y; Fukushi J; Hori S; Matsuda N; Okatsu K; Kakiyama Y; Kawawaki J; Kakizuka A; Tanaka K
    Genes Cells; 2013 Dec; 18(12):1131-43. PubMed ID: 24215292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An intrinsically disordered motif regulates the interaction between the p47 adaptor and the p97 AAA+ ATPase.
    Conicella AE; Huang R; Ripstein ZA; Nguyen A; Wang E; Löhr T; Schuck P; Vendruscolo M; Rubinstein JL; Kay LE
    Proc Natl Acad Sci U S A; 2020 Oct; 117(42):26226-26236. PubMed ID: 33028677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The AAA ATPase p97/VCP interacts with its alternative co-factors, Ufd1-Npl4 and p47, through a common bipartite binding mechanism.
    Bruderer RM; Brasseur C; Meyer HH
    J Biol Chem; 2004 Nov; 279(48):49609-16. PubMed ID: 15371428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p37 regulates VCP/p97 shuttling and functions in the nucleus and cytosol.
    Wrobel L; Hoffmann JL; Li X; Rubinsztein DC
    Sci Adv; 2024 May; 10(18):eadl6082. PubMed ID: 38701207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. D1 ring is stable and nucleotide-independent, whereas D2 ring undergoes major conformational changes during the ATPase cycle of p97-VCP.
    Wang Q; Song C; Yang X; Li CC
    J Biol Chem; 2003 Aug; 278(35):32784-93. PubMed ID: 12807884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inclusion body myopathy, Paget's disease of the bone and fronto-temporal dementia: a disorder of autophagy.
    Ju JS; Weihl CC
    Hum Mol Genet; 2010 Apr; 19(R1):R38-45. PubMed ID: 20410287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural basis of the interaction between the AAA ATPase p97/VCP and its adaptor protein p47.
    Dreveny I; Kondo H; Uchiyama K; Shaw A; Zhang X; Freemont PS
    EMBO J; 2004 Mar; 23(5):1030-9. PubMed ID: 14988733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.